KOL Perspectives: Adaptive Trial Designs in IBD

Market: Pharmaceuticals and Healthcare

Global, 27 pages report, published by GlobalData

Report ThumbnailAugust-2018
KOL Perspectives: Adaptive Trial Designs in IBD

Summary

This KOL Insight briefing focuses on KOLs views of Adaptive trial designs in IBD.

Questions topics -
- Current challenges in IBD clinical trials
- Adaptive Phase II/III trial designs
- Guselkumab’s Phase II/III trial in Crohn’s disease
- Novel clinical trials in IBD

Key Highlights

- Most KOLs highlighted that recruitment is the greatest challenge in IBD clinical trials, both across Crohn’s disease & UC
- Most KOLs flagged Phase II/III

Read More
  • Table of Contents
  • Executive Summary
  • Background
  • Research Panel Composition
  • Results & Implications
  • Appendix
Read More

Please select a license type

Share

Related Products

GlobalDataKOL Perspectives: Adaptive Trial Designs in IBDProduct ThumbnailKOL Perspectives: Adaptive Trial Designs in IBD, Industry ReportProduct #: 1194199
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2019 Global Market Analyst. All Rights Reserved